» Articles » PMID: 7192182

The Interaction of Misonidazole with Radiation, Chemotherapeutic Agents, or Heat: a Preliminary Report

Overview
Specialties Oncology
Pharmacology
Date 1980 Jan 1
PMID 7192182
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Survival of hypoxic cells exposed to misonidazole at 37 degrees C show an initial lag period after which survival decreases exponentially with time. Hypoxic cells incubated with misonidazole for a time equivalent to that of the lag period on the survival curve show increased sensitivity when subsequently given x-irradiation. This is consistent with previously published observations. In addition, preincubation of hypoxic cells with misonidazole ata 37 degrees C also renders cells more sensitive to subsequent treatments by heat or melphalan, mustine and cis-Pt(II). Preincubation must be in hypoxia for cells to become sensitive to a second insult; preincubation in air does not change cellular sensitivity even when this preexposure is 5 mM misonidazole for 3 days. The potential of exploiting a physiological property of most solid tumors, viz., hypoxia, in order to increase sensitivity of tumor cells to cytotoxic agents is discussed.

Citing Articles

Effect of hyperthermia on the activity of 1-[(4'-hydroxy-2'-butenoxy)methyl]-2-nitroimidazole, which is cytotoxic to hypoxic cells.

Kusumoto T, Maehara Y, Emi Y, Sakaguchi Y, Baba H, Sakaguchi M Cancer Chemother Pharmacol. 1993; 31(6):455-8.

PMID: 8453684 DOI: 10.1007/BF00685035.


Interactions between misonidazole and hyperthermia in EMT6 spheroids.

Morgan J, Bleehen N Br J Cancer. 1981; 44(6):810-8.

PMID: 7326192 PMC: 2010874. DOI: 10.1038/bjc.1981.279.


Enhancement of the effect of cytotoxic drugs by radiosensitizers.

Martin W, McNally N, De Ronde J Br J Cancer. 1981; 43(6):756-66.

PMID: 7248157 PMC: 2010716. DOI: 10.1038/bjc.1981.113.


Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.

Stephens T, COURTENAY V, Mills J, Peacock J, Rose C, Spooner D Br J Cancer. 1981; 43(4):451-7.

PMID: 7236488 PMC: 2010637. DOI: 10.1038/bjc.1981.66.


Potentiation of melphalan activity against a murine tumour by nitroimidazole compounds.

SHELDON P, Batten E, Adams G Br J Cancer. 1982; 46(4):525-31.

PMID: 7138761 PMC: 2011202. DOI: 10.1038/bjc.1982.236.